4,692
Views
9
CrossRef citations to date
0
Altmetric
Review

Repurposing CD8+ T cell immunity against SARS-CoV-2 for cancer immunotherapy: a positive aspect of the COVID-19 pandemic?

, , & ORCID Icon
Article: 1794424 | Received 28 Jun 2020, Accepted 06 Jul 2020, Published online: 16 Jul 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Articles from other publishers (9)